|
End-of-day quote
Korea S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 3,395.00 KRW | -3.41% |
|
+4.46% | -50.65% |
| 04-14 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-03 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOME & COMPANY | Other Biotechnology & Medical Research | -3.41% | +4.46% | -50.65% | +24.36% | -85.54% | 133M |
-
|
-
|
-
|
- Stock Market
- Stocks
- A314130 Stock
- Charts Genome & Company
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
